GlassScriptPhysician profile
James J Fowler
NPI 1891790499
$4,716.80
in general payments reported to CMS, 2019-2025
12 companies · $1,227 in 2025
The $1,227 reported for 2025 was more than what 83% of Otolaryngology providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $117 · 2020: $15.39 · 2021: $73.81 · 2022: $437 · 2023: $1,595 · 2024: $1,252 · 2025: $1,227.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,154 · Travel and Lodging: $920.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,153.71 |
| Travel and Lodging | $920.01 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $2,761.84 | 2022-2025 | Nuvent, Propel, Stealthstation S8 Platform |
| Inspire Medical Systems, INC. | $1,348.56 | 2022-2025 | Inspire |
| Stryker Corporation | $124.01 | 2019-2022 | |
| Smith+Nephew, INC. | $95.34 | 2021-2024 | Tula |
| Balt USA, LLC | $91.90 | 2024 | Optima Coil System, Raptor Aspiration Catheter |
| Regeneron Healthcare Solutions, INC. | $80.25 | 2023-2024 | Dupixent |
| Acclarent, INC | $75.77 | 2019-2022 | |
| Integra Lifesciences Corporation | $49.26 | 2025 | Trudi Probe, Relieva Spinplus Nav, Inspira Air |
| Optinose US, INC. | $37.10 | 2023 | |
| Phadia US INC. | $21.01 | 2023 | Immunocap |
| Philips North America LLC | $16.37 | 2019 | |
| Medtronic USA, INC. | $15.39 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw James Fowler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.